• 1
    Health and Welfare Statistics Association. Main indication for public health. J. Health Welfare Stat. 2005; 49: 3478 (in Japanese).
  • 2
    Sunderland T, Hill JL, Mellow AM et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J. Am. Geriatr. Soc. 1989; 37: 725729.
  • 3
    Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS. Screening for Alzheimer's disease by clock drawing. J. Am. Geriatr. Soc. 1989; 37: 730734.
  • 4
    Mendez MF, Ala T, Underwood KL. Development of scoring criteria for the clock drawing task in Alzheimer's disease. J. Am. Geriatr. Soc. 1992; 40: 10951099.
  • 5
    Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL. The clock test: A sensitive measure to differentiate normal elderly from those with Alzheimer disease. J. Am. Geriatr. Soc. 1992; 40: 579584.
  • 6
    Rouleau I, Salmon DP, Butters N. Longitudinal analysis of clock drawing in Alzheimer's disease patients. Brain Cogn. 1996; 347: 696697.
  • 7
    Shulman KI. Clock-drawing: Is it the ideal cognitive screening test? Int. J. Geriatr. Psychiatry 2000; 15: 548561.
  • 8
    Powlishta KK, Von Dras DD, Stanford A et al. The clock drawing test is a poor screen for very mild dementia. Neurology 2002; 59: 898903.
  • 9
    Isobe C, Kayano K, Tsuchida S, Ishii Y, Takahashi M, Miyaoka H. Clock drawing test in the point of screening test for dementia. A comparative study between CDT and RCPM. Kanagawa Psychiatry 2004; 54: 2533 (in Japanese).
  • 10
    Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M. Neural correlates of impaired performance on the clock drawing test in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2005; 19: 390396.
  • 11
    Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann. Nucl. Med. 2001; 15: 8592.
  • 12
    Twamley EW, Ropacki SA, Bondi MW. Neuropsychological and neuroimaging change in preclinical Alzheimer's disease. J. Int. Neuropsychol. Soc. 2006; 12: 707735.
  • 13
    Ueda H, Kitabayashi Y, Narumoto J et al. Relationship between clock drawing test performance and regional cerebral blood flow in Alzheimer's disease: A single photon emission computed tomography study. Psychiatry Clin. Neurosci. 2002; 56: 2529.
  • 14
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34: 939944.
  • 15
    Petersen RC, Smith GE, Waring SC, Ivnic RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch. Neurol. 1999; 56: 303308.
  • 16
    Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn. 1992; 43: 7087.
  • 17
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’ a practical method for grading the cognitive state for the clinician. J. Psychiatry Res. 1975; 12: 189198.
  • 18
    Hughes CP, Berg L, Danziger RL, Coben LA, Martin RL. Clinical scale for the staging of dementia. Br. J. Psychiatry 1982; 140: 566572.
  • 19
    Wechsler D. The Wechsler Memory Scale – Revised Manual. Psychological Corporation, San Antonio, TX, 1987.
  • 20
    Arthur G. A Point Scale of Performance Test (Revised Form II). Psychological Corporation, New York, 1947.
  • 21
    Takeuchi R, Yonekura Y, Takeda SK, Fujita K, Konishi J. Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: Validation using magnetic resonance imaging – technical note. Neurol. Med. Chir. (Tokyo) 2003; 43: 153162.
  • 22
    Takeuchi R, Matsuda H, Yoshioka K, Yonekura Y. Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT. Eur. J. Nucl. Med. Mol. Imaging 2004; 31: 578589.
  • 23
    Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSTR and fine SRT. Radiat. Med. 2006; 24: 538544.
  • 24
    Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl) 1991; 82: 239259.
  • 25
    Arriagada PV, Growdon JH, Hedley-Whyte ET et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631639.
  • 26
    Sabbagh MN, Lynn P, Jhingran S et al. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 1997; 9: 6874.
  • 27
    Mimura M, Yano M. Memory impairment and awareness of memory deficits in early-stage Alzheimer's disease. Rev. Neurosci. 2006; 17: 253266.
  • 28
    Riddle W, O'Carroll RE, Dougall N et al. A single photon emission computerized tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia. Br. J. Psychiatry 1993; 163: 166172.
  • 29
    Garrido GEJ, Furuie SS, Buchpiguel CA et al. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: A combined MRI and SPECT study. J. Neurol. Neurosurg. Psychiatry 2002; 73: 508516.
  • 30
    Grady CL, Furey ML, Pietro P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 2001; 124: 739756.
  • 31
    Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th edn. Oxford University Press, New York, 2004.
  • 32
    Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 13801386.
  • 33
    Petersen RC, Jack CR, Xu YC et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000; 54: 581587.
  • 34
    Tanaka M, Fukuyama H, Yamauchi H et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J. Neuroimaging 2002; 12: 112118.
  • 35
    Lin KN, Wang PN, Chen C et al. The three-item clock drawing test: A simplified screening test for Alzheimer's disease. Eur. Neurol. 2003; 49: 5358.
  • 36
    Beinhoff U, Hilbert V, Bittner D, Gron G, Riepe MW. Screening for cognitive impairment: A triage for outpatient care. Dement. Geriatr. Cogn. Disord. 2005; 20: 278285.
  • 37
    Keilp JG, Alexander GE, Stern Y, Prohovnik I. Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease. Brain Cogn. 1996; 32: 365383.
  • 38
    Elgh E, Sundstrom T, Nasman B, Ahlstrom R, Nyberg L. Memory functions and cCBF (99m)Tc-HMPAO SPET: Developing diagnostics in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2002; 29: 11401148.